Many neurological disorders such as epilepsy, Parkinson’s, multiple sclerosis, Alzheimer’s or stroke are chronic or cause chronic sequalae with fluctuating dynamics. However, current hospital- and appointment-based patient care provides «snap-shot»-like information only, thereby strongly undersampling the time course of a disease. At NeuroTec, a newly founded research and development platform located at the Swiss Institute for Translational and Entrepreneurial Medicine (sitem) and run by the Department of Neurology in close collaboration with ARTORG, an interdisciplinary team of physicians, engineers and data scientists strives at closing this information gap. New devices and methods that allow to record digital biomarkers in the everyday out-of-hospital life of patients are tested. The goal is to monitor the individual course of a patient’s disease and thus enable personalized diagnostics and therapies on an unprecedented scale.